Predictors of successful neoadjuvant treatment in HER2‑positive breast cancer

The prognosis of local or locally advanced human epidermal growth factor receptor 2 (HER2)-positive breast cancer after a complete response from neoadjuvant systemic treatment (NAT) is excellent. However, some of the patients succumb to their disease, so novel predictive factors to identify these pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hännikäinen, Elli-Noora, Mattson, Johanna, Karihtala, Peeter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472020/
https://www.ncbi.nlm.nih.gov/pubmed/37664661
http://dx.doi.org/10.3892/ol.2023.14021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472020/
https://www.ncbi.nlm.nih.gov/pubmed/37664661
http://dx.doi.org/10.3892/ol.2023.14021

Ejemplares similares